Mukesh Mahajan Email and Phone Number

A quality-driven scientific leader with 18 years of experience in research and development within the biologics industry, specializing in biosimilars and vaccines. Proficient in analytical product development, having worked on around 20 biosimilars at various stages, including 2 USFDA-approved and 9 DCGI-approved products, with hands-on experience from inception to launch.Currently a dynamic cross-functional leader at Kashiv Biosciences, overseeing global tech transfer, due diligence, and new technology exploration. Leads a skilled analytical team focusing on method development, validation, biosimilarity studies, and impurity characterization. Advocates for “Blended Learning” in project management across Kashiv's diverse portfolio.Previously at Enzene Biosciences, managed a team of innovative scientists handling product characterization, method development, and biosimilarity studies for monoclonal antibodies and peptibodies.Spent a decade at Zydus (Cadila Healthcare), where I led a team in CMC writing, method development, and validation for a broad range of biologics, including monoclonal antibodies and ADCs. Key roles included setting up validation teams, method transfer, and managing R&D activities.At USV, focused on technology transfer and pilot plant setup for peptide production.Holds a Master of Technology in Biotechnology and an MBA in Project Management.Supported commercially approved products Exemptia™, TwinRab™, Bonmax®PTH, Bryxta™, Vivitra™, Pegstim®, Colstim®, UJVIRA™, Releuko® and Fylnetra®